The President of theNankai University, Tianjin, China;Professor and Director, Center for Immunotherapy, Chinese Academy of Medical Sciences, Beijing, China;Professor and Director, National Key Laboratory of Medical Immunology, Second Military Medical University (SMMU), Shanghai, China.
Xuetao Cao received his M.D. and Ph.D. from Second Military Medical University (SMMU) (1986 and 1990, Shanghai, China). He became a full Professor of Immunology at SMMU in 1992, and served Chinese Academy of Medical Sciences as President during 2011-2017. Now, Dr. Cao is the President of Nankai University (Tianjin, China).
Dr. Cao's research focuses on innate immunity and inflammation, tumor immunotherapy. His group has made contributions to our understanding of innate signaling in immunity and inflammation, the identification of regulatory immune cell subsets and translational research of cancer immunotherapy.
Dr. Cao was elected as member of American Academy of Arts and Sciences (2018),US National Academy of Medicine (2017), UK Academy of Medical Sciences (2016), EMBO (2015), German Academy of Sciences (2013), Chinese Academy of Engineering (2005). As corresponding author, he has published more than 250 original papers in peer-reviewed journals including Cell, Nature, Science, Nature Immunology, Immunity, etc. He is the Founder Editor of Chinese Journal of Cancer Biotherapy ,Co-Editor-in-Chief of Cellular and Molecular Immunology, Senior Editor of Cancer Immunology Research, and serves on the editorial board of journals such as Cell, eLife, Cell Res.